The identification of bladder cancer biomarker-nuclear matrix protein 22 (NMP22) was accomplished by deploying a sensitive electrochemical immunosensor exploiting reduced GO-tetraethylene pentamine (rGO-TEPA) and trimetallic Au-Pd-Pt NPs. The gene discussed is NUMA1; the disease is urinary bladder carcinoma.